JNK-IN-7

CAS No. 1408064-71-0

JNK-IN-7 ( JNK-IN-7; JNK inhibitor;JNKIN7; JNK IN 7 )

Catalog No. M17280 CAS No. 1408064-71-0

JNK-IN-7 is a selective JNK1/2/3 inhibitor (IC50: 1.54/1.99/0.75 nM). It can also inhibit phosphorylation of c-Jun, which is a substrate of JNK kinase.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 145 In Stock
5MG 214 In Stock
10MG 275 In Stock
25MG 495 In Stock
50MG 713 In Stock
100MG 972 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JNK-IN-7
  • Note
    Research use only, not for human use.
  • Brief Description
    JNK-IN-7 is a selective JNK1/2/3 inhibitor (IC50: 1.54/1.99/0.75 nM). It can also inhibit phosphorylation of c-Jun, which is a substrate of JNK kinase.
  • Description
    JNK-IN-7 is a relatively selective JNKs inhibitor(IC50= 1.54/1.99/0.75 for JNK1/2/3); also bound to IRAK1, PIK3C3, PIP5K3 and PIP4K2C.
  • Synonyms
    JNK-IN-7; JNK inhibitor;JNKIN7; JNK IN 7
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    JNK1; JNK2; JNK3
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1408064-71-0
  • Formula Weight
    493.56
  • Molecular Formula
    C28H27N7O2
  • Purity
    98%
  • Solubility
    DMSO : 33.33 mg/mL. 67.53 mM; H2O : < 0.1 mg/mL
  • SMILES
    C(=O)(Nc1cccc(c1)C(=O)Nc1ccc(cc1)Nc1nccc(n1)c1cnccc1)/C=C/CN(C)C
  • Chemical Name
    3-[[(E)-4-(Dimethylamino)but-2-enoyl]amino]-N-[4-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang T, et al. Chem Biol, 2012, 19(1): 140-154.
molnova catalog
related products
  • EGF Receptor Substra...

    EGF Receptor Substrate 2 (Phospho-Tyr5) is a biologically active peptide derived from an autophosphorylation site (Tyr992) of EGFR.

  • EGFRvIII peptide PEP...

    PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.

  • N-trans-caffeoyltyra...

    N-trans-caffeoyltyramine is a novel and potent modulator of inflammatory responses.